Nephrology Consultants, LLC

Huntsville, Alabama 35805-4104

3 studies enrolling now · 18 studies all time

What they study most

ADPKD, Arteriovenous Fistula, Autosomal Dominant Polycystic Kidney, Chronic Kidney Disease, Chronic Kidney Failure, Complication of Hemodialysis, Complication of Renal Dialysis, Diabetic Nephropathies, ESRD, End Stage Kidney Disease, End Stage Renal Disease, Hyperphosphatemia

Studies at this site

• PODOMOUNT-Basket, a Study to Test Whether BI 764198 Helps Adults and Adolescents With Different Types of Kidney Disease — Recruiting now
• Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1-Mediated Proteinuric Kidney Disease — Recruiting now
• Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD) — Recruiting now
• A Study Called FINE-REAL to Learn More About the Use of the Drug Finerenone in a Routine Medical Care Setting — Running, not enrolling
• Inaxaplin in Participants With Proteinuric APOL1 Mediated Kidney Disease With or Without Comorbidities — Running, not enrolling
• A Study to Learn About How Well BAY3283142 Works and Its Safety in Participants With Chronic Kidney Disease — Completed
• A Study of Zigakibart in Adults With IgA Nephropathy — Running, not enrolling
• A Trial to Learn How Well Finerenone Works and How Safe it is in Adult Participants With Non-diabetic Chronic Kidney Disease — Completed
• A Study to Test BI 764198 in People With a Type of Kidney Disease Called Focal Segmental Glomerulosclerosis — Completed
• Trial to Evaluate the Sirolimus-Eluting Collagen Implant on AV Fistula Outcomes — Completed
• EMPA-KIDNEY (The Study of Heart and Kidney Protection With Empagliflozin) — Completed
• A Trial of Bardoxolone Methyl in Patients With ADPKD - FALCON — Stopped early
• A Study to Examine Past Estimated Glomerular Filtration Rate (eGFR) Slope as a Risk Marker for Rapid Kidney Function Decline in People With Chronic Kidney Disease — Stopped early
• Study to Evaluate the Efficacy of Tenapanor as Adjunctive Therapy to Phosphate Binder Therapy — Completed
• Efficacy and Safety of Lixivaptan in the Treatment of Autosomal Dominant Polycystic Kidney Disease — Stopped early
• A Natural History Study to Assess the Clinical Outcomes of Patients With Complement Factor I Deficiency-Mediated Disease — Stopped early
• Screening Study to Identify Patients With Complement Factor I Deficiencies — Stopped early
• This Study Tests a New Medicine Called BI 685509 in Patients That Have Kidney Problems Because of Diabetes. The Study Tests How BI 685509 is Taken up in the Body and How Well it is Tolerated (Multiple Rising Doses) — Completed